Slabý O - Search Results

1

[Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].

Slabý O, Krekác D, Hrstka R, Svoboda M, Vyzula R. Slabý O, et al. Cas Lek Cesk. 2008;147(1):25-31. Cas Lek Cesk. 2008. PMID: 18323039 Review. Czech.

2

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer.

Slaby O, Bienertova-Vasku J, Svoboda M, Vyzula R. Slaby O, et al. J Cell Mol Med. 2012 Jan;16(1):8-21. doi: 10.1111/j.1582-4934.2011.01359.x. J Cell Mol Med. 2012. PMID: 21692980 Free PMC article. Review.

3

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application.

Slaby O, Svoboda M, Michalek J, Vyzula R. Slaby O, et al. Mol Cancer. 2009 Nov 14;8:102. doi: 10.1186/1476-4598-8-102. Mol Cancer. 2009. PMID: 19912656 Free PMC article. Review.

4

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R. Slaby O, et al. Oncology. 2007;72(5-6):397-402. doi: 10.1159/000113489. Epub 2008 Jan 15. Oncology. 2007. PMID: 18196926 Clinical Trial.

5

[Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study].

Garajová I, Slabý O, Svoboda M, Fabian P, Silák J, Smerdová T, Kocák I, Růzicková J, Hoch J, Vyzula R. Garajová I, et al. Among authors: slaby o. Cas Lek Cesk. 2008;147(7):381-6. Cas Lek Cesk. 2008. PMID: 18678097 Slovak.

6

[DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].

Slabý O, Svoboda M, Michálek J, Vyzula R. Slabý O, et al. Klin Onkol. 2009;22(5):202-9. Klin Onkol. 2009. PMID: 19886357 Review. Czech.

7

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R. Slaby O, et al. J Exp Clin Cancer Res. 2010 Jul 7;29(1):90. doi: 10.1186/1756-9966-29-90. J Exp Clin Cancer Res. 2010. PMID: 20609231 Free PMC article.

8

MicroRNAs and their target gene networks in renal cell carcinoma.

Redova M, Svoboda M, Slaby O. Redova M, et al. Among authors: slaby o. Biochem Biophys Res Commun. 2011 Feb 11;405(2):153-6. doi: 10.1016/j.bbrc.2011.01.019. Epub 2011 Jan 11. Biochem Biophys Res Commun. 2011. PMID: 21232526 Review.

9

MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.

Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O, Vyzula R. Svoboda M, et al. Among authors: slaby o. Diagn Pathol. 2012 Mar 22;7:31. doi: 10.1186/1746-1596-7-31. Diagn Pathol. 2012. PMID: 22439831 Free PMC article.

10

Identification and functional screening of microRNAs highly deregulated in colorectal cancer.

Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, Nekvindova J, Radova L, Fabian P, Slaba K, Kiss I, Vyzula R, Slaby O. Faltejskova P, et al. Among authors: slaby o. J Cell Mol Med. 2012 Nov;16(11):2655-66. doi: 10.1111/j.1582-4934.2012.01579.x. J Cell Mol Med. 2012. PMID: 22469014 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters